Actininopathy: A new muscular dystrophy caused by ACTN2 dominant mutations.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
06 2019
Historique:
received: 04 11 2018
revised: 07 02 2019
accepted: 17 03 2019
pubmed: 23 3 2019
medline: 31 3 2020
entrez: 23 3 2019
Statut: ppublish

Résumé

To clinically and pathologically characterize a cohort of patients presenting with a novel form of distal myopathy and to identify the genetic cause of this new muscular dystrophy. We studied 4 families (3 from Spain and 1 from Sweden) suffering from an autosomal dominant distal myopathy. Affected members showed adult onset asymmetric distal muscle weakness with initial involvement of ankle dorsiflexion later progressing also to proximal limb muscles. In all 3 Spanish families, we identified a unique missense variant in the ACTN2 gene cosegregating with the disease. The affected members of the Swedish family carry a different ACTN2 missense variant. ACTN2 encodes for alpha actinin2, which is highly expressed in the sarcomeric Z-disk with a major structural and functional role. Actininopathy is thus a new genetically determined distal myopathy. ANN NEUROL 2019;85:899-906.

Identifiants

pubmed: 30900782
doi: 10.1002/ana.25470
doi:

Substances chimiques

ACTN2 protein, human 0
Actinin 11003-00-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

899-906

Subventions

Organisme : Finska Läkaresällskapet
Pays : International
Organisme : ISCIII PI14/00738, FEDER funds "a way to achieve Europe''
Pays : International
Organisme : Jane ja Aatos Erkon Säätiö
Pays : International
Organisme : Liv&Hälsa
Pays : International
Organisme : Magnus Ehrnroothin Säätiö
Pays : International
Organisme : Sigrid Juselius foundation
Pays : International
Organisme : Academy of Finland
Pays : International
Organisme : Liv & Hälsa Foundation
Pays : International
Organisme : Erkko Foundation
Pays : International
Organisme : ISCIII
ID : PI14/00738
Pays : International
Organisme : Finnish Medical Foundation
Pays : International
Organisme : Magnus Ehrnrooth Foundation
Pays : International

Informations de copyright

© 2019 American Neurological Association.

Auteurs

Marco Savarese (M)

Folkhälsan Research Center, Helsinki, Finland.
Medicum, University of Helsinki, Helsinki, Finland.

Johanna Palmio (J)

Neuromuscular Research Center, Tampere University Hospital and Tampere University, Tampere, Finland.

Juan José Poza (JJ)

Department of Neurology, Donostia University Hospital, San Sebastián, Spain.

Jan Weinberg (J)

Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.

Montse Olive (M)

Department of Pathology, Neuropathology and Neuromuscular Unit, Biomedical Research Institute of Bellvitge, Bellvitge University Hospital, Hospitalet de Llobregat, Spain.

Ana Maria Cobo (AM)

Neuromuscular Diseases Center of Competence, Marin Hospital, Public Hospital Network of Paris, Hendaye, France.

Anna Vihola (A)

Folkhälsan Research Center, Helsinki, Finland.
Medicum, University of Helsinki, Helsinki, Finland.

Per Harald Jonson (PH)

Folkhälsan Research Center, Helsinki, Finland.
Medicum, University of Helsinki, Helsinki, Finland.

Jaakko Sarparanta (J)

Folkhälsan Research Center, Helsinki, Finland.
Medicum, University of Helsinki, Helsinki, Finland.

Federico García-Bragado (F)

Department of Neurology, Donostia University Hospital, San Sebastián, Spain.

Jon Andoni Urtizberea (JA)

Neuromuscular Diseases Center of Competence, Marin Hospital, Public Hospital Network of Paris, Hendaye, France.

Peter Hackman (P)

Folkhälsan Research Center, Helsinki, Finland.
Medicum, University of Helsinki, Helsinki, Finland.

Bjarne Udd (B)

Folkhälsan Research Center, Helsinki, Finland.
Medicum, University of Helsinki, Helsinki, Finland.
Neuromuscular Research Center, Tampere University Hospital and Tampere University, Tampere, Finland.
Department of Neurology, Vaasa Central Hospital, Vaasa, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH